MedPath

The Effects of Short-Term Romosozumab Treatment on Hip Strength

Not Applicable
Conditions
Patients with osteoporosis
Registration Number
JPRN-UMIN000052357
Lead Sponsor
Showa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria were patients with illnesses affecting bone and calcium metabolism or bone disorders other than osteoporosis, any malignant conditions, fresh fracture, scheduled surgery, severe renal dysfunction or history of cardiovascular events.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bone strength of the hip
Secondary Outcome Measures
NameTimeMethod
3D-BMD(Bone mineral density)
© Copyright 2025. All Rights Reserved by MedPath